366 related articles for article (PubMed ID: 17453399)
1. Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: a double-blind randomized trial of 100 patients with 1-year follow-up.
Grohs JG; Schmidt M; Wanivenhaus A
Acta Orthop; 2007 Feb; 78(1):95-8. PubMed ID: 17453399
[TBL] [Abstract][Full Text] [Related]
2. Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty.
van der Heide HJ; Rijnberg WJ; Van Sorge A; Van Kampen A; Schreurs BW
Acta Orthop; 2007 Feb; 78(1):90-4. PubMed ID: 17453398
[TBL] [Abstract][Full Text] [Related]
3. Rofecoxib inhibits heterotopic ossification after total hip arthroplasty.
van der Heide HJ; Koorevaar RC; Lemmens JA; van Kampen A; Schreurs BW
Arch Orthop Trauma Surg; 2007 Sep; 127(7):557-61. PubMed ID: 17106714
[TBL] [Abstract][Full Text] [Related]
4. Selective cyclooxygenase-2 (COX-2) inhibition reduces proteinuria in renal patients.
Vogt L; de Zeeuw D; Woittiez AJ; Navis G
Nephrol Dial Transplant; 2009 Apr; 24(4):1182-9. PubMed ID: 19037084
[TBL] [Abstract][Full Text] [Related]
5. No difference between two doses of diclofenac in prophylaxis of heterotopic ossifications after total hip arthroplasty.
Sell S; Phillips O; Handel M
Acta Orthop Scand; 2004 Feb; 75(1):45-9. PubMed ID: 15022805
[TBL] [Abstract][Full Text] [Related]
6. Short term prophylaxis against heterotopic bone after cementless hip replacement.
Wurnig C; Auersperg V; Boehler N; Steindl M; Kiss H; Zweymuller K; Kotz R
Clin Orthop Relat Res; 1997 Jan; (334):175-83. PubMed ID: 9005911
[TBL] [Abstract][Full Text] [Related]
7. [Clinical study on the prevention of heterotopic ossification after total hip arthroplasty by Xiaozhong Zhitong].
Liu HP; Li YJ; Wang CX; Li SH; Zhao ZW; Wang JH
Zhongguo Gu Shang; 2011 Oct; 24(10):857-60. PubMed ID: 22097138
[TBL] [Abstract][Full Text] [Related]
8. Celecoxib versus ibuprofen in the prevention of heterotopic ossification following total hip replacement: a prospective randomised trial.
Saudan M; Saudan P; Perneger T; Riand N; Keller A; Hoffmeyer P
J Bone Joint Surg Br; 2007 Feb; 89(2):155-9. PubMed ID: 17322426
[TBL] [Abstract][Full Text] [Related]
9. Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled study.
Bogaty P; Brophy JM; Noel M; Boyer L; Simard S; Bertrand F; Dagenais GR
Circulation; 2004 Aug; 110(8):934-9. PubMed ID: 15302800
[TBL] [Abstract][Full Text] [Related]
10. Stable bony integration with and without short-term indomethacin prophylaxis. A 5-year follow-up.
Trnka HJ; Zenz P; Zembsch A; Easley M; Ritschl P; Salzer M
Arch Orthop Trauma Surg; 1999; 119(7-8):456-60. PubMed ID: 10613239
[TBL] [Abstract][Full Text] [Related]
11. Comparative clinical study of the prophylaxis of heterotopic ossifications after total hip arthroplasty using etoricoxib or diclofenac.
Winkler S; Springorum HR; Vaitl T; Handel M; Barta S; Kehl V; Craiovan B; Grifka J
Int Orthop; 2016 Apr; 40(4):673-80. PubMed ID: 26728611
[TBL] [Abstract][Full Text] [Related]
12. [Indomethacin in the prevention of para-articular ossification following total hip endoprosthesis].
Hochheim B; Wünsche F
Beitr Orthop Traumatol; 1990 Jun; 37(6):330-4. PubMed ID: 2117436
[TBL] [Abstract][Full Text] [Related]
13. Combining paracetamol with a selective cyclooxygenase-2 inhibitor for acute pain relief after third molar surgery: a randomized, double-blind, placebo-controlled study.
Haglund B; von Bültzingslöwen I
Eur J Oral Sci; 2006 Aug; 114(4):293-301. PubMed ID: 16911100
[TBL] [Abstract][Full Text] [Related]
14. Is etoricoxib effective in preventing heterotopic ossification after primary total hip arthroplasty?
Brunnekreef JJ; Hoogervorst P; Ploegmakers MJ; Rijnen WH; Schreurs BW
Int Orthop; 2013 Apr; 37(4):583-7. PubMed ID: 23359100
[TBL] [Abstract][Full Text] [Related]
15. Heterotopic bone formation in total hip arthroplasty: predisposing factors, classification and the significance for clinical outcome.
Schara K; Herman S
Acta Chir Orthop Traumatol Cech; 2001; 68(2):105-8. PubMed ID: 11706718
[TBL] [Abstract][Full Text] [Related]
16. [Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials].
Xu BG; Xue DT; Wang XH; Yan SG
Zhongguo Gu Shang; 2014 Jul; 27(7):609-14. PubMed ID: 25338452
[TBL] [Abstract][Full Text] [Related]
17. [Prevention of heterotopic ossification after THA with indomethacin: analysis of risk factors].
Zehetgruber H; Grübl A; Goll A; Schwameis E; Wurnig C; Giurea A
Z Orthop Ihre Grenzgeb; 2005; 143(6):631-7. PubMed ID: 16380894
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological treatment of heterotopic ossification following hip and acetabular surgery.
Macfarlane RJ; Ng BH; Gamie Z; El Masry MA; Velonis S; Schizas C; Tsiridis E
Expert Opin Pharmacother; 2008 Apr; 9(5):767-86. PubMed ID: 18345954
[TBL] [Abstract][Full Text] [Related]
19. NSAID switching and short-term gastrointestinal outcome rates after the withdrawal of rofecoxib.
Schneeweiss S; Glynn RJ; Avorn J; Mamdani M; Mogun H; Solomon DH
Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1134-42. PubMed ID: 19844943
[TBL] [Abstract][Full Text] [Related]
20. Heterotopic ossification in patients after total hip replacement.
Stołtny T; Koczy B; Wawrzynek W; Miszczyk L
Ortop Traumatol Rehabil; 2007; 9(3):264-72. PubMed ID: 17721424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
